Tauseefullah Akhund

Senior Director, Global Clinical Program Lead - Vaccines & Immune Therapies @AstraZeneca

Cambridgeshire, GB

Played a Key role in the approval of the first Home /self-care administration of the intranasal Flu vaccine - Recognized by Time magazine Led global clinical program development for the Influenza, RSV, COVID-19 vaccine, and CMV mAbs, enabling broader vaccine accessibility and pandemic preparedness. Successfully expanded Influenza approvals in many countries, supporting local immunization programs and enhancing global public health impact. Directed external research for label updates, driving market expansion and strengthening post-marketing evidence. Co-led the development of the ChAdOx COVID-19 vaccine with Oxford University. Delivered beta variant COVID-19 vaccine trial, published in The Lancet Microbe. Provided key scientific insights on variant response, guiding global booster strategies.

Western Sydney University

Master of Public Health (MPH), Public Health

Università di Siena

Master of Science (Msc) in Vaccinology & Pharmaceutical Clinical Development, Masters in Vaccinology and Pharmaceutical Clinical Development

Chandka Medical College

Bachelor of Medicine, Bachelor of Surgery (MBBS) (MD)

University of Geneva

ADVAC. Advance Course of Vaccinology, Vaccines, Completion 60 European CME credits, Advanced Course of Vaccinology – ADVAC at Annecy, France by Foundation of Merieux and Univ.of Geneva